APR 20, 2015 11:07 AM PDT

Stronger Protein-Nanoparticle Marriage Shows Promise for HIV, Cancer Treatments

WRITTEN BY: Will Hector
Fastening protein-based medical treatments to nanoparticles isn't easy.

With arduous chemistry, scientists can do it. But like a doomed marriage, the fragile binding that holds them together often separates.

This problem, which has limited how doctors can use proteins to treat serious disease, may soon change.
The image above illustrates how proteins (copper-colored coils) modified with polyhistidine-tags (green diamonds) can be attached to nanoparticles (red circle).
University at Buffalo researchers have discovered a way to easily and effectively fasten proteins to nanoparticles -- essentially an arranged marriage -- by simply mixing them together. The biotechnology, described April 20 online in the journal Nature Chemistry, is in its infancy. But it already has shown promise for developing an HIV vaccine and as a way to target cancer cells.

"Scientists have been able to attach proteins to nanoparticles for a while now. But it's a fairly difficult process that's only effective in a controlled environment. Nobody has been able to devise a simple method that can work inside the body," said Jonathan F. Lovell, PhD, UB assistant professor of biomedical engineering, who led the research.

He added: "We have proven that you can easily attach proteins to nanoparticles and, like Velcro that doesn't unstick, it stays together."

Additional authors include researchers from UB's Department of Chemical and Biological Engineering and Department of Microbiology and Immunology.

To create the biotechnology, the researchers use nanoparticles made of chlorophyll (a natural pigment), phospholipid (a fat similar to vegetable oil) and cobalt (a metal often used to prepare magnetic, water-resistant and high-strength alloys).

The proteins, meanwhile, are modified with a chain of amino acids called a polyhistidine-tag. Uncommon in medicine, polyhistidine-tags are used extensively in protein research.

Next, the researchers mixed the modified proteins and nanoparticles in water. There, one end of the protein embeds into the nanoparticle's outer layer while the rest of it sticks out like a tentacle.

To test the new binding model's usefulness, the researchers added to it an adjuvant, which is an immunological agent used to enhance the efficacy of vaccines and drug treatments. The results were impressive. The three parts -- adjuvant, protein and nanoparticle -- worked together to stimulate an immune response against HIV.

The researchers also tested proteins that target cancer cells. Again, the results were exciting, with the new binding model acting like a homing missile to tumors. The targeted nanoparticles have the potential to improve cancer treatment by targeting specific cancer cells in lieu of releasing anti-cancer drugs everywhere in the body.

Lovell plans to follow up the research with more rigorous testing of the vaccine and tumor-targeted technologies. Moving to human clinical trials is the ultimate goal.

Follow Will Hector: @WriteCompassion

(Sources: University of Buffalo; Science Daily)
About the Author
  • Will Hector practices psychotherapy at Heart in Balance Counseling Center in Oakland, California. He has substantial training in Attachment Theory, Hakomi Body-Centered Psychotherapy, Psycho-Physical Therapy, and Formative Psychology. To learn more about his practice, click here: http://www.heartinbalancetherapy.com/will-hector.html
You May Also Like
SEP 15, 2020
Cardiology
Dopamine Could Cause Heart Arrhythmia After Heart Failure
SEP 15, 2020
Dopamine Could Cause Heart Arrhythmia After Heart Failure
Everyone knows that friend with a tattoo of a molecule of dopamine. Usually associated with the pleasure response, it is ...
NOV 11, 2020
Health & Medicine
A smart path for novel biologics
NOV 11, 2020
A smart path for novel biologics
Introduction  Cell culture is at the heart of the production process for many biopharmaceuticals, but finding the o ...
OCT 25, 2020
Cell & Molecular Biology
Revealing More About the Genetics of Ewing Sarcoma
OCT 25, 2020
Revealing More About the Genetics of Ewing Sarcoma
Ewing sarcoma is a rare kind of cancer that tends to impact young people and occurs in bones or the tissue around them. ...
NOV 03, 2020
Cell & Molecular Biology
The Connections Between Toxins, Genes, and Disease
NOV 03, 2020
The Connections Between Toxins, Genes, and Disease
We are exposed to a vast array of chemicals every day. Many are harmless or even important, like the air we breathe, wat ...
NOV 23, 2020
Cell & Molecular Biology
Vibrations in Coronavirus Proteins Help Them Infect Cells
NOV 23, 2020
Vibrations in Coronavirus Proteins Help Them Infect Cells
If a key isn't cut quite right, it might need a special jiggle to get it into a lock in the right way. Scientists have n ...
NOV 27, 2020
Cell & Molecular Biology
UVC Rays May be a Bigger Cancer Risk Than Known
NOV 27, 2020
UVC Rays May be a Bigger Cancer Risk Than Known
The sun emits different kinds of light and rays including visible and ultraviolet (UV) and infrared. Some of those forms ...
Loading Comments...